Publications by authors named "Geeke J Waverijn"
Rheumatol Ther
August 2022
Article Synopsis
- The study analyzed the effects of switching adult patients with rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis from the reference drug adalimumab (Humira®) to its biosimilar (Amgevita®).
- Out of 603 patients, over 93% successfully transitioned without significant changes in disease activity or safety, confirming the equivalence of the two treatments.
- Some patients experienced nocebo effects, highlighting the importance of addressing patient perceptions to optimize treatment outcomes and maintain cost benefits of using biosimilars.
